Why Allogene Stock Is Trading Down Today
Portfolio Pulse from Ryan Gustafson
Allogene Therapeutics' CFO Eric Schmidt is stepping down from his position, causing the company's stock to trade lower. Schmidt will remain with the company until August 2, 2023, to ensure an orderly transition. Allogene has initiated a search for a new CFO.
June 14, 2023 | 6:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Allogene Therapeutics' stock is trading lower due to the announcement of CFO Eric Schmidt stepping down. The company is searching for a new CFO.
The announcement of CFO Eric Schmidt stepping down has led to uncertainty and concerns about the company's future financial management. This has resulted in a negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100